You are viewing archived content
Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.
Table TDI-22. Secondary drugs cited by clients entering treatment, 2011 or most recent year available
Part (ii) Inpatient units
| Secondary drug | Number of citations by all clients | % |
|---|---|---|
| Volatile Inhalants | 323 | 0.8 |
| Hallucinogens | 385 | 1.0 |
| Stimulants | 2917 | 7.3 |
| Cocaine | 3509 | 8.8 |
| Opioids | 3569 | 8.9 |
| Hypotics and Sedatives | 3796 | 9.5 |
| Other Substances | 5569 | 14.0 |
| Alcohol | 8968 | 22.5 |
| Cannabis | 10879 | 27.3 |
| Total number of citations | 39915 | 100 |
Notes
For information on the countries supplying data and the number of treatment clients in each country see Table TDI-7.
See also 'General notes for interpreting data' on the Explanatory notes and help page.
Source:
Reitox national reports 2012 — Table TDI by centre type.